Literature DB >> 1740418

Epidermal growth factor enhances a microsomal 12-lipoxygenase activity in A431 cells.

W C Chang1, C C Ning, M T Lin, J D Huang.   

Abstract

12-Hydroxyeicosatetraenoic acid (12-HETE) is formed from arachidonic acid either by 12-lipoxygenase or by a cytochrome P450 monooxygenase. 12-Lipoxygenase is generally localized in the soluble cytosolic fraction, and the cytochrome P450 monooxygenase is a microsomal enzyme. In this study, 12-HETE biosynthesis and the regulation of 12-HETE biosynthesis by epidermal growth factor (EGF) in A431 cells were investigated. 12-HETE was biosynthesized from arachidonic acid by the microsomal fraction of A431 cells, but not by the cytosolic fraction. The formation of 12-HETE was inhibited by 5,8,11,14-eicosatetraynoic acid, nordihydroguaiaretic acid, and caffeic acid. Nordihydroguaiaretic acid at 10(-4) M and 5,8,11,14-eicosatetraynoic acid at 10(-5) M almost completely inhibited its formation. However, the formation of 12-HETE was not affected by the presence of an NADPH-generating system, carbon monoxide, or SKF 525A. The biosynthetic 12-HETE was analyzed by chiral stationary phase high performance liquid chromatography and was highly enriched in (12S)-HETE. We therefore concluded that the enzyme responsible for the formation of (12S)-HETE in the microsomes of A431 cells is a 12-lipoxygenase. The microsomal 12-lipoxygenase of A431 cells belongs to the "leukocyte-type" enzyme as determined by substrate specificity and enzyme kinetics studies. The microsomal 12-lipoxygenase oxygenated linoleic acid much faster than the cytosolic platelet 12-lipoxygenase and is a "self-catalyzed inactivation" enzyme. Treatment of cells with 50 ng/ml EGF significantly induced microsomal 12-lipoxygenase activity. The lag period for the expression of the stimulatory effect of EGF on 12-lipoxygenase activity was approximately 10 h. The stimulatory effect of EGF on 12-lipoxygenase activity was completely blocked by treatment with 35 microM cycloheximide, indicating a requirement for de novo protein biosynthesis. Furthermore, the presence of the endogenous inhibitor of 12-lipoxygenase (which masked (12S)-HETE biosynthesis in intact cells) was identified in the cytosolic fraction of A431 cells. The putative inhibitor was enzyme-selective. It inhibited the leukocyte-type 12-lipoxygenase, but not the "platelet-type" enzyme.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740418

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Transcriptional activation of human 12-lipoxygenase gene promoter is mediated through Sp1 consensus sites in A431 cells.

Authors:  Y W Liu; T Arakawa; S Yamamoto; W C Chang
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

2.  Functional interaction between c-Jun and promoter factor Sp1 in epidermal growth factor-induced gene expression of human 12(S)-lipoxygenase.

Authors:  B K Chen; W C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

3.  Characterization and purification of a lipoxygenase inhibitor in human epidermoid carcinoma A431 cells.

Authors:  C J Chen; H S Huang; Y T Lee; C Y Yang; W C Chang
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

4.  Lipoxygenase in Human Tumor Cells.

Authors:  Wolfgang Hagmann
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

Review 5.  12-lipoxygenases and 12(S)-HETE: role in cancer metastasis.

Authors:  K V Honn; D G Tang; X Gao; I A Butovich; B Liu; J Timar; W Hagmann
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

6.  Involvement of PKC-alpha in regulatory volume decrease responses and activation of volume-sensitive chloride channels in human cervical cancer HT-3 cells.

Authors:  C Y Chou; M R Shen; K S Hsu; H Y Huang; H C Lin
Journal:  J Physiol       Date:  1998-10-15       Impact factor: 5.182

7.  Novel anti-tumour activity of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4- benzoquinone (CV-6504) against established murine adenocarcinomas (MAC).

Authors:  H J Hussey; M C Bibby; M J Tisdale
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.